Meeting Preview: AMCP Nexus 2021

Attendees of AMCP Nexus 2021 will have the opportunity to connect with and learn from more than an expected 2500+ member and nonmember managed care decision makers back in person at the Gaylord Rockies in Denver, CO, October 18-21. Like previous AMCP events, managed care pharmacists, pharmacy benefit managers, physicians, nurses, health plan administrators, and other professionals will gather to learn together about new practices in the industry, especially one struck by COVID-19.

This learning comes at a crucial time as we work to implement challenging health care reforms and navigate a world ravaged by the COVID-19 pandemic. It is more important than ever to connect with peers and learn and discuss the pressing topics of today that could shape the industry forever.

At AMCP Nexus 2021, attendees will have the opportunity to attend various education sessions
focused on the latest data and managed care solutions. The conference will also feature 3 keynote presentations with an opening general session featuring Sekou Andrews, an award-winning schoolteacher turned actor, recording artist, two-time national poetry slam champion, and entrepreneur.

Attendees will also have ample networking and connection opportunities at The Exchange (formerly known as The Exposition), where more than 70 exhibitors will showcase their latest innovations and products to improve patient outcomes, as well as job performance. Come visit the Population Health Learning Network and pick up the latest issue of First Report Managed Care at Booth #419.

In an effort to help conference attendees navigate this year’s AMCP Nexus schedule, as well as ensure the most valuable sessions will not be missed, First Report Managed Care has curated a brief overview of sessions. Please always refer to the final program and meeting website (2021.AMCPnexus.org) for the complete list of sessions, speakers, and events.

EDUCATION TRACKS

The AMCP educational tracks allow professionals, ranging from medical directors to nurses, to customize their meeting experience. Attendees can easily use the color-coded session to navigate the meeting tracks to get the most pertinent data and insight. We have highlighted some of the tracks and schedule below.

HIGHLIGHTED SESSIONS

Tuesday, October 19, 2021

10:00AM-11:15AM
Addressing Gene Therapy Financial Challenges: A Survey of Emerging Market Solutions
Jane F Barlow, MD, MPH, MBA, and Michelle Harika, PharmD, review and highlight unique aspects of emerging market products leveraging a survey conducted by MIT, as well as offer insight on risk carve-out, contracting and data management, and provider contracting. Attendees of this session will be able to identify unique financing challenges associated with gene therapies and learn about potential actionable next steps.

1:00PM-2:15PM
Partnering with Actuaries for Effective Value-Based Payment Models
Joan Barrett, FSA, MAAA, Nicole Bulochnik, MS, PharmD, BCPS, BCCCP, CRC, and Ian Smith, FSA, MAAA, FCA, will discuss the recent shift from traditional fee-for-service payment models to value-based, and offer insight into how actuarial models can integrate clinical and financial data to help create an overall strategy and improve the adoption of value-based payment models.

Wednesday, October 20, 2021

10:00AM-11:15AM
Biosimilars’ Impact on Health Care Trends and Costs
Jeffrey Casberg, MS, RPh, and Leslie Fish, RPh, PharmD, discuss the initial slow uptake of biosimilars in the United States and how the trends are shifting in relations to formulary placement strategies, true product costs, and contracting availability. This session will include information on market launch cost trends, 340B pricing, and barriers and tactics influencing biosimilar uptake.

4:40PM-5:45PM
Managing Chronic Kidney Disease: The Impact of Reducing End-Stage Renal Disease Progression and Complications
Kimberly Grant, PharmD, and Andrew Levitsky, PharmD, BCPS, will discuss the current chronic kidney disease population, including end-stage renal disease; explain current challenges faced by payers attempting to manage therapies; examine the latest therapies; and describe factors applicable to determining the budget impact of said therapies to improve care for this patient population.

Thursday, October 21, 2021

8:15AM-9:30AM
KEYNOTE: Part D’s Sweet Sixteen: How is the Benefit Adapting to Address the Challenges of Today and Tomorrow?
Melissa Andel, MPP, and Babette S Edgar, PharmD, MBA, FAMCP, will help attendees understand the landscape of today’s Part D benefit, how recent changes have impacted plans and beneficiaries and how plans are adapting to new policies introduced since 2020. This keynote session will also look ahead and discuss some potential policies that could be coming over the horizon.

SATELLITE SYMPOSIA
In addition to the education sessions at AMCP Nexus 2021, AMCP offers a series of 12 satellite symposia that offer credit for continuing pharmacy, medical, and nursing education. The noncommercial, grant-funded learning activities include sessions on optimizing clinical outcomes for intravenous iron therapies, sickle cell disease, atopic dermatitis, multiple sclerosis, oncology, and more.